Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar bedford777 (37.21) Submitted: 4/23/2008 10:45:32 AM : Outperform Start Price: $6.97 OMPI Score: +83.42

This undervalued skin care company with a fairly strong financial statement will appreciate a minimum of 15% each year over the next five years. It is so low that a much larger company could try to purchase this to take advantage of its lineup.

Featured Broker Partners


Advertisement